| 中文名称: | (+)-氯前列烯醇 |
| 中文别名: | ( )-氯前列烯醇;(5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-氯苯氧基)-3-羟基-1-丁烯-1-基]-3,5-二羟基环戊基]-5-庚烯酸;(+)-氯前列醇;(+)-氯前列烯醇;氯前列烯醇 |
| smiles: | OC(CCC/C=C\C[C@@H]1[C@H]([C@H](O)C[C@@H]1O)/C=C/[C@@H](O)COC2=CC(Cl)=CC=C2)=O |
| 英文名称: | (+)-Cloprostenol (D-Cloprostenol) |
| 英文别名: | ( )-Cloprostenol;(5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid;(+)-Cloprostenol;(+/-)-9-methyl-3,9-diazabicyclo[4.2.1]nonane;(Z)-7-(2-((E)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid;3,9-Diazabicyclo[4.2.1]nonane,9-methyl-;9-methyl-3,9-diazabicyclo-[4.2.1]nonane;9-methyl-3,9-diazabicyclo-[4.2.1]-nonane;9-METHYL-3,9-DIAZABICYCLO[4.2.1]NONANE;ACMC-20m5i7;AGN-PC-00BJCD;Cloprostenol;CTK4;SureCN929913;EINECS 255-028-8;EINECS 255-028-8;HMS3402O21;HMS3402O21;5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-rel-;5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-rel-;(+-)-(Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(3-Chlorophenoxy-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptensaeure;(+-)-(Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(3-Chlorophenoxy-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptensaeure;GTPL1894;GTPL1894;NCGC00161343-03;NCGC00161343-03;(Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-Chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid;(Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-Chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid;16-(M-CHLOROPHENOXY)-17,18,19,20-TETRANORPROSTAGLANDIN F2.ALPHA.;16-(M-CHLOROPHENOXY)-17,18,19,20-TETRANORPROSTAGLANDIN F2.ALPHA.;AC-6104;AC-6104;(+-)-Cloprostenol;(+-)-Cloprostenol;DTXSID7048372;DTXSID7048372;5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1-alpha-(Z),2-beta-(1E,3R*),3-alpha,5-alpha)- (+-)-;5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1-alpha-(Z),2-beta-(1E,3R*),3-alpha,5-alpha)- (+-)-;HMS1989O21;HMS1989O21;SR-01000946503-1;SR-01000946503-1;cloprostenol;cloprostenol;5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-;CLOPROSTENOL, (+/-)-;5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-;Estrophan;CLOPROSTENOL, (+/-)-;16-(m-Chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2alpha;Estrophan;Q27076117;16-(m-Chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2alpha;Cloprostenolum (INN-Latin);Q27076117;CS-7779;Cloprostenolum (INN-Latin);(Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-Chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoicacid;CS-7779;52EJR3Y9IN;(Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-Chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoicacid;(Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoic acid;52EJR3Y9IN;REL-(5Z)-7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-CHLOROPHENOXY... |
| CAS号: | 54276-21-0 |
| 分子式: | C22H29CLO6 |
| 分子量: | 424.92 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
(+)-氯前列烯醇
英文名:
(+)-Cloprostenol (D-Cloprostenol)
别名:( )-氯前列烯醇;(5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-氯苯氧基)-3-羟基-1-丁烯-1-基]-3,5-二羟基环戊基]-5-庚烯酸;(+)-氯前列醇;(+)-氯前列烯醇;氯前列烯醇
商品编号:R122797-5mg
规格:5mg
纯度:98%
CAS号: 54276-21-0
分子式:C22H29CLO6
分子量:424.92
| 价格 |
¥ 1140.00
(请 登录 会员查看折扣价)
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















